Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Phase 2 Study to Further Assess the Efficacy, Safety and Dose Response of KYG0395 in the Treatment of Primary Dysmenorrhea

NCT01588236 is registered in ClinicalTrials.gov with Jiangsu Kanion Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT01588236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01588236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Phase 2 Study to Further Assess the Efficacy, Safety and Dose Response of KYG0395 in the Treatment of Primary Dysmenorrhea
Lead sponsor
Jiangsu Kanion Pharmaceutical Co., Ltd
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
July 31, 2015
Enrollment
280 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

primary dysmenorrhea